Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Neurology

Surgical and Neuromodulation Options

At a Glance

When medication does not control mesial temporal lobe epilepsy with hippocampal sclerosis, anterior temporal lobectomy or laser therapy may stop seizures in carefully selected patients, while RNS or VNS usually reduce them. Presurgical testing guides the safest choice.

When medications do not control Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-HS), your care team may suggest procedures to stop or reduce your seizures. These options fall into two main categories: potentially seizure-free treatments, which aim to stop seizures entirely, and seizure-reducing treatments, which aim to reduce the frequency and intensity of seizures [1][2].

Potentially Seizure-Free Options: Removing the Source

If your seizures start in one specific, clearly identified spot (unilateral), doctors may recommend removing or destroying that tissue. Both procedures carry risks such as bleeding, infection, and changes to memory or language [3].

Anterior Temporal Lobectomy (ATL)

This is the “gold standard” surgery for MTLE-HS and has been performed for decades [1]. A surgeon removes a portion of the temporal lobe, including the scarred hippocampus [4].

  • Success Rate: This offers a high chance of becoming completely seizure-free. Studies show that roughly 60% to 80% of carefully selected patients achieve seizure freedom after ATL [1][3].
  • The Trade-off: It is an invasive open-brain surgery and requires a longer recovery time. Because it involves removing brain tissue, there is a risk of changes to your verbal memory (especially if the surgery is on your dominant side) and small changes to your peripheral vision [3][5].

Laser Interstitial Thermal Therapy (LITT)

This is a newer, minimally invasive alternative to ATL. A surgeon uses a laser probe, guided by a real-time MRI, to ablate the scarred hippocampus through a tiny hole in the skull [6].

  • Success Rate: Seizure-freedom rates for LITT are often slightly lower than for ATL, typically ranging from 55% to 66% in selected groups [6][7].
  • The Advantage: Recovery is much faster, often involving only a short hospital stay [1]. Because the laser is very precise, it may carry a lower risk for certain types of memory and language decline compared to traditional surgery for some patients [8]. However, it is still invasive brain surgery with risks of bleeding or incomplete ablation.

Seizure-Reducing Options: Calming the Network

If your seizures come from both sides of the brain, are poorly localized, or if surgery is too risky, your team may suggest neuromodulation. These devices do not remove tissue; instead, they use electrical pulses to “interrupt” seizure activity [2].

Responsive Neurostimulation (RNS)

The RNS System is like a “brain pacemaker.” A device is placed in the skull with wires leading to one or two identified seizure foci. It constantly monitors your brain waves and delivers a small electrical pulse when it detects abnormal activity [9].

  • Results: Most patients see a significant reduction in seizures (median reduction of about 70% after several years), but it rarely stops all seizures permanently [9].
  • Benefit: It provides your doctors with years of data on your brain activity, which can help fine-tune your treatment, though it requires programming and battery changes [10].

Vagus Nerve Stimulation (VNS)

A VNS device is implanted under the skin of the chest, with a wire wrapped around the vagus nerve in the neck. It sends regular pulses of electricity to the brain to help modulate the seizure network [11].

  • Results: Similar to RNS, it is designed to reduce seizures over time. About 50% of patients see their seizure frequency cut in half after a year or two of treatment [12][11].
  • Side Effects: You may notice temporary hoarseness, a “tickle” in the throat, or shortness of breath while the device is actively stimulating the nerve [12].

Making the Choice

Choosing between these options requires careful presurgical evaluation to determine your candidacy based on your brain network, not just your preference for a shorter recovery. Your multidisciplinary team will help you weigh the risks and benefits of each option.

Common questions in this guide

When is surgery considered for mesial temporal lobe epilepsy with hippocampal sclerosis?
Surgery may be considered when medicines do not control seizures and testing shows that seizures begin in one clearly identified area. An epilepsy surgery team evaluates the seizure network, memory, language, and other risks before recommending a procedure.
What is the difference between ATL and LITT for MTLE-HS?
Anterior temporal lobectomy removes part of the temporal lobe, including the scarred hippocampus, while laser interstitial thermal therapy uses an MRI-guided probe to heat and destroy the scarred tissue through a small skull opening. LITT generally has a faster recovery, whereas ATL has more established and often higher seizure-free rates in selected patients.
How likely are ATL or LITT to stop seizures completely?
Among carefully selected patients, about 60% to 80% become seizure-free after ATL, compared with roughly 55% to 66% after LITT. These figures are group estimates, and your expected outcome depends on seizure location, brain-network findings, and other individual factors.
Do RNS and VNS stop seizures or only reduce them?
RNS and VNS are designed mainly to reduce seizure frequency and intensity rather than remove the seizure source. RNS detects abnormal brain activity and responds with an electrical pulse, while VNS sends regular pulses through the vagus nerve; many patients improve, but complete seizure freedom is uncommon.
What side effects and risks should I discuss before epilepsy surgery or stimulation?
Brain surgery can cause bleeding, infection, memory or language changes, and small peripheral-vision changes, with the exact risk depending on the procedure and side of surgery. VNS may cause temporary hoarseness, a throat tickle, or shortness of breath during stimulation. RNS requires ongoing programming and battery changes.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Mesial temporal lobe epilepsy with hippocampal sclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I a candidate for a 'potentially seizure-free' procedure like ATL or LITT, or is my seizure network better suited for a 'seizure-reducing' neuromodulation device?
  2. 2.Based on my neuropsychological testing, which procedure offers the best balance between stopping seizures and protecting my memory and language?
  3. 3.If I choose LITT and it does not stop my seizures, would I still be a candidate for an ATL later on?
  4. 4.What is your surgical team's specific success rate for seizure freedom in patients with hippocampal sclerosis using ATL versus LITT?
  5. 5.For RNS or VNS, what kind of seizure reduction can I realistically expect over the first two to three years?

References

References (12)
  1. 1

    Minimally invasive surgical approaches for temporal lobe epilepsy.

    Chang EF, Englot DJ, Vadera S

    Epilepsy & behavior : E&B 2015; (47()):24-33.

    PMID: 26017774
  2. 2

    Putting it all together: Options for intractable epilepsy: An updated algorithm on the use of epilepsy surgery and neurostimulation.

    Benbadis SR, Geller E, Ryvlin P, et al.

    Epilepsy & behavior : E&B 2018; (88S()):33-38 doi:10.1016/j.yebeh.2018.05.030.

    PMID: 30241957
  3. 3

    Long-term predictors of seizure outcome after anterior temporal lobectomy in unilateral hippocampal sclerosis: A 281-patient cohort with mean 10-year follow-up.

    Rodrigues TP, Bocca LF, Yacubian EMT, et al.

    Epileptic disorders : international epilepsy journal with videotape 2026; (28(1)):84-96 doi:10.1002/epd2.70139.

    PMID: 41277760
  4. 4

    Postsurgical outcomes in a cohort of patients with hippocampal sclerosis: Initial experience in a referral epilepsy center in Peru.

    De La Cruz Ramirez WF, Chacón Zuñiga DE, Sánchez-Boluarte SS, et al.

    Epilepsia open 2023; (8(3)):1175-1181 doi:10.1002/epi4.12784.

    PMID: 37394997
  5. 5

    Complications After Surgery for Mesial Temporal Lobe Epilepsy Associated with Hippocampal Sclerosis.

    Mathon B, Navarro V, Bielle F, et al.

    World neurosurgery 2017; (102()):639-650.e2 doi:10.1016/j.wneu.2017.03.128.

    PMID: 28389411
  6. 6

    Comparison of minimally invasive and traditional surgical approaches for refractory mesial temporal lobe epilepsy: A systematic review and meta-analysis of outcomes.

    Kohlhase K, Zöllner JP, Tandon N, et al.

    Epilepsia 2021; (62(4)):831-845 doi:10.1111/epi.16846.

    PMID: 33656182
  7. 7

    Surgical Outcomes of Laser Interstitial Thermal Therapy for Temporal Lobe Epilepsy: Systematic Review and Meta-analysis.

    Kerezoudis P, Parisi V, Marsh WR, et al.

    World neurosurgery 2020; (143()):527-536.e3 doi:10.1016/j.wneu.2020.07.194.

    PMID: 32750511
  8. 8

    Neuropsychological outcomes comparing traditional surgical approaches and laser interstitial thermal therapy for refractory mesial temporal lobe epilepsy: A systematic review and meta-analysis.

    Stavrogianni K, Poprelka K, Fasilis T, et al.

    Epilepsia 2026; (67(2)):588-605 doi:10.1111/epi.18687.

    PMID: 41108633
  9. 9

    Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy.

    Geller EB, Skarpaas TL, Gross RE, et al.

    Epilepsia 2017; (58(6)):994-1004 doi:10.1111/epi.13740.

    PMID: 28398014
  10. 10

    Long-Term Intracranial EEG Lateralization of Epileptogenicity in Patients With Confirmed or Suspected Bilateral Mesial Temporal Lobe Onsets During Epilepsy Surgical Evaluation.

    Arain AM, Mirro EA, Brown D, et al.

    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2024; (41(6)):522-529 doi:10.1097/WNP.0000000000001028.

    PMID: 37934087
  11. 11

    Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry.

    Kawai K, Tanaka T, Baba H, et al.

    Epileptic disorders : international epilepsy journal with videotape 2017; (19(3)):327-338 doi:10.1684/epd.2017.0929.

    PMID: 28832004
  12. 12

    Vagus nerve stimulation for focal seizures.

    Panebianco M, Rigby A, Marson AG

    The Cochrane database of systematic reviews 2022; (7()):CD002896 doi:10.1002/14651858.CD002896.pub3.

    PMID: 35833911

This page is for informational purposes only and does not constitute medical advice. Your epilepsy surgery team can use your testing and seizure history to discuss which option is safest for you.